Minerva Neurosciences (NERV) Treasury Shares (2013 - 2020)
Minerva Neurosciences (NERV) reported Treasury Shares of $48650.0 for Q3 2020, down 61.78% on a YoY basis from $127300.0 in Q4 2019, and little changed quarter-over-quarter from $48650.0 in Q2 2020.
Minerva Neurosciences (NERV) Treasury Shares (2013 - 2020) Analysis & Trends
Minerva Neurosciences has reported Treasury Shares for 7 years, with the latest figure at $48650.0 in Q3 2020.
- For the quarter ending Q3 2020, Treasury Shares fell 61.78% year-over-year to $48650.0; the trailing twelve-month figure through Sep 2020 stood at $48650.0 (down 61.78% YoY), and the FY2019 full-year result was $68650.0, down 46.07% from the prior year.
- Treasury Shares for Q3 2020 stood at $48650.0, roughly flat from $48650.0 in the prior quarter.
- The five-year high for Treasury Shares was $3.9 million in Q4 2017, with the low at $48650.0 in Q2 2020.
- Historically, Treasury Shares has averaged $376394.1 across 5 years, with a median of $156625.0 in 2018.
- Annual changes were most pronounced in 2017 — Treasury Shares surged 1672.43% — and 2018, when it sank 96.73%.
- Minerva Neurosciences' Treasury Shares stood at $219600.0 in 2016, then surged by 1672.43% to $3.9 million in 2017, then slumped by 96.73% to $127300.0 in 2018, then tumbled by 46.07% to $68650.0 in 2019, then retreated by 29.13% to $48650.0 in 2020.
- The last three Treasury Shares figures came in at $48650.0 (Q3 2020), $48650.0 (Q2 2020), and $68650.0 (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Minerva Neurosciences | 197.55 Mn | 197.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 48,650.00 |
| Sep 30, 2020 | 48,650.00 |
| Jun 30, 2020 | 48,650.00 |
| Jun 30, 2020 | 48,650.00 |
| Mar 31, 2020 | 68,650.00 |
| Mar 31, 2020 | 68,650.00 |
| Dec 31, 2019 | 68,650.00 |
| Dec 31, 2019 | 68,650.00 |
| Sep 30, 2019 | 127,300.00 |
| Sep 30, 2019 | 127,300.00 |
| Jun 30, 2019 | 127,300.00 |
| Jun 30, 2019 | 127,300.00 |
| Mar 31, 2019 | 127,300.00 |
| Mar 31, 2019 | 127,300.00 |
| Dec 31, 2018 | 127,300.00 |
| Dec 31, 2018 | 127,300.00 |
| Sep 30, 2018 | 185,950.00 |
| Sep 30, 2018 | 185,950.00 |
| Jun 30, 2018 | 185,950.00 |
| Jun 30, 2018 | 185,950.00 |